Press Releases :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences is a consumer wellness company specializing in nutraceuticals and plant-based foods.

Press Releases

CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

Sep 27, 2022

CV Sciences, Inc. Extinguishes Convertible Debt

Aug 25, 2022

CV Sciences, Inc. Announces Launch of PlusCBD™ Reserve Collection Softgels

Aug 15, 2022

CV Sciences, Inc. Reports Second Quarter 2022 Financial Results

Aug 15, 2022

CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2022 RESULTS ON AUGUST 15, 2022

Aug 9, 2022

CV Sciences, Inc. Reports First Quarter 2022 Financial Results

May 16, 2022

CV Sciences, Inc. to Announce First Quarter 2022 Results On May 16, 2022

May 12, 2022

CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results

Mar 31, 2022

CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 31, 2022

Mar 28, 2022

UPDATE -- CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products

Mar 11, 2022